SEC Form 4 · accession 0001209191-15-061547
ARATANA THERAPEUTICS, INC. · PETX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jay Lichter
Director
Period of report
Jul 15, 2015
Accepted (ET)
Jul 17, 2015 · 5:39 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001509190
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| COMMON STOCKF1 | Jul 15, 2015 | J | 1,000,000 | $0.00 | D | 2,345,543 | I | BY LIMITED PARTNERSHIP |
| COMMON STOCKF2 | holding | — | — | — | 29,025 | I | BY LIMITED LIABILITY COMPANIES |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents the aggregate number of shares of common stock distributed by Avalon Ventures IX, L.P. ("Avalon Ventures LP") on a pro rata basis for no consideration to its limited partners (the "Distribution"). The Reporting Person is a managing director of Avalon Ventures LP and shares voting and dispositive power over the shares held by Avalon Ventures LP. The Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein.
- F2Represents 9,025 shares held by Avalon Ventures IX Management, LLC ("Avalon Ventures LLC") and 20,000 shares acquired by Avalon Ventures IX GP, LLC ("Avalon Ventures IX GP") pursuant to the Distribution. The Reporting Person is a manager of Avalon Ventures LLC and Avalon Ventures IX GP and shares voting and dispositive power over the shares held by such entities. The Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein.